Dr. David Amron Discusses Liposuction as an Advanced

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Dr. David Amron Discusses Liposuction as an Advanced Lipedema Treatment at the Fat Disorders Research Society’s Annual Conference

Los Angeles, April 08, 2016 (GLOBE NEWSWIRE) -- Liposuction expert Dr. David Amron will be a key speaker at the Fat Disorders Research Society (FDRS) 2016 Conference in St. Louis, Missouri on April 8 through 10 at The Marriot St. Louis Airport hotel. With this year’s conference titled “Living with Lipedema and Dealing with Dercum’s Disease,” the Beverly Hills, California-based dermatologic surgeon, who is considered a pioneer in lipedema treatment, has been invited to speak on his unique circumferential approach to liposuction on the conference’s surgical panel.

“I’m very happy to once again attend the FDRS conference,” said Dr. Amron. “Despite the large number of individuals suffering with lipedema, it is still a disease that is both commonly misdiagnosed and mistreated. In fact, because of its high risk, many surgeons refuse to treat lipedema patients. At this conference, I plan to not only expand my own knowledge of the disease, but also to help educate attendees about my very real and successful treatment method.”

Currently, it is estimated that more than 17 million women nationwide struggle with lipedema, a fat storage condition affecting the limbs. The only known treatment option shown to work is pure tumescent liposuction, which Dr. Amron is an expert in. Using proprietary techniques, he has already helped hundreds of patients with the disease make the return to full mobility.

Annually, the FDRS conference brings together top physicians and researchers in the industry to discuss, educate, and network on topics surrounding adipose tissue disorders and treatment options. This year, in addition to Dr. Amron’s discussion on treating lipedema with liposuction, attendees can also look forward to lectures on properly diagnosing the disease, as well as information on proper nutrition, exercise, and therapies for lipedema.

To find out more about the FDRS 2016 conference, please visit: http://www.fatdisorders.org/ . For more information or to schedule an appointment with Dr. Amron, please visit: www.amronmd.com and www.theroxburyinstitute.com , or call (424) 394-1610.

###

 

About David Amron, M.D.

Dr. David Amron is a board certified dermatologic surgeon specializing in lipedema treatment, liposuction, and body contouring. He is medical director of the Roxbury Institute in Beverly Hills, California and has a worldwide reputation for excellence in successfully approaching complicated liposuction cases, including lipedema treatments and revision liposuction surgeries. He also specializes in nonsurgical facial rejuvenation and is internationally renowned for his artistry and unique approach to lipo-sculpture surgery.

Matt Rindone, Media Representative matt@tylerbarnettpr.com 323.937.1951

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 380

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 283

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 284

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 56

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 460

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 220

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 226

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 423

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 448

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 301

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Viasat's Commitment to Shareholders and Future Growth Strategies

Updated Category News Views 168

Viasat's Commitment to Shareholders Viasat, Inc. (NASDAQ: VSAT), a renowned leader in satellite communications, has emphasized its dedication to engaging constructively with shareholders. Recently, the company addressed feedback from Carronade Capital Management, reaffirming its mission to maximize shareholder value. Engaging Constructively with Stakeholders In its...

Continue Reading
Investing in Class Actions: What Shareholders Need to Know

Updated Category News Views 234

Understanding Class Action Lawsuits for Investors With the increasing complexities of the stock market, investors must stay informed about their rights and the challenges they may face. Class action lawsuits arise when a group of investors suffer losses due to misstatements or fraud by a company. Recently, three companies, Metagenomi, AMMO, and Paragon 28, are under...

Continue Reading
David Samuelson Takes on Leadership Role at Alliance for Decision Education

Updated Category News Views 286

Exciting Leadership Changes within the Alliance for Decision Education David Samuelson, a notable figure in education technology, has been appointed as the Executive Director of the Alliance for Decision Education. This organization is committed to enhancing decision-making education across schools nationwide. Samuelson brings a wealth of expertise, having served in...

Continue Reading
Anticipation Builds as Strawberry Fields REIT Prepares to Report Earnings

Updated Category News Views 125

Overview of Strawberry Fields REIT Earnings Expectations Strawberry Fields REIT (NASDAQ: STRW) is preparing to announce its quarterly earnings shortly. Investors are eager to know what the company will reveal regarding its financial performance. The anticipation is high as expectations build within the market. Analyst Expectations for Earnings Performance Financial...

Continue Reading
Pomerantz Investigates Securities Claims for Investors of PSN

Updated Category News Views 172

Pomerantz LLP's Investigation into Parsons Corporation Pomerantz LLP has initiated an investigation concerning claims made on behalf of investors of Parsons Corporation (NYSE: PSN). This inquiry is focused on whether the Company, including its officers or directors, might have participated in unlawful business practices, including securities fraud. Concerns About...

Continue Reading